FI280574A7 - - Google Patents

Info

Publication number
FI280574A7
FI280574A7 FI2805/74A FI280574A FI280574A7 FI 280574 A7 FI280574 A7 FI 280574A7 FI 2805/74 A FI2805/74 A FI 2805/74A FI 280574 A FI280574 A FI 280574A FI 280574 A7 FI280574 A7 FI 280574A7
Authority
FI
Finland
Application number
FI2805/74A
Other languages
Finnish (fi)
Inventor
U Kerb
R Wiechert
L Alig
A Fuerst
M Mueller
P Keller
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI280574A7 publication Critical patent/FI280574A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
FI2805/74A 1973-09-26 1974-09-26 FI280574A7 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732349024 DE2349024A1 (de) 1973-09-26 1973-09-26 6beta,7beta-epoxy-1alpha,2alphamethylen-d-homo-4-pregnen-3,20-dione

Publications (1)

Publication Number Publication Date
FI280574A7 true FI280574A7 (enExample) 1975-03-27

Family

ID=5894080

Family Applications (1)

Application Number Title Priority Date Filing Date
FI2805/74A FI280574A7 (enExample) 1973-09-26 1974-09-26

Country Status (16)

Country Link
US (1) US3965128A (enExample)
JP (1) JPS5059362A (enExample)
AR (1) AR202946A1 (enExample)
AU (1) AU7374074A (enExample)
BE (1) BE820381A (enExample)
DD (1) DD114599A5 (enExample)
DE (1) DE2349024A1 (enExample)
DK (1) DK507974A (enExample)
FI (1) FI280574A7 (enExample)
FR (1) FR2244492A1 (enExample)
IL (1) IL45629A0 (enExample)
LU (1) LU70985A1 (enExample)
NL (1) NL7412747A (enExample)
NO (1) NO743449L (enExample)
SE (1) SE7412058L (enExample)
ZA (1) ZA746131B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1399199A (en) * 1997-11-14 1999-06-07 Merck & Co., Inc. Immunosuppressant tetracyclic triterpenes
US6022890A (en) * 1997-11-14 2000-02-08 Merck & Co., Inc. Immunosuppressant tetracyclic triterpenes
US8093273B2 (en) 2004-10-20 2012-01-10 Resverlogix Corp. Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
EP1909788A2 (en) * 2005-07-29 2008-04-16 Resverlogix Corp. Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
US8053440B2 (en) 2007-02-01 2011-11-08 Resverlogix Corporation Compounds for the prevention and treatment of cardiovascular diseases
ES2532402T3 (es) 2008-06-26 2015-03-26 Resverlogix Corporation Métodos de preparación de derivados de quinazolinona
WO2010079431A2 (en) 2009-01-08 2010-07-15 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular disease
CA2992231C (en) 2009-03-18 2022-03-29 Resverlogix Corp. Phenyl-quinazolin-4(3h)-one and phenyl-pyrido[2,3-d]pyrimidin-4(3h)-one derivatives and compositions thereof useful as anti-inflammatory agents
ES2706651T3 (es) 2009-04-22 2019-03-29 Resverlogix Corp Nuevos agentes antiinflamatorios
SI2773354T1 (sl) 2011-11-01 2019-08-30 Resverlogix Corp. Peroralne formulacije s takojšnjim sproščanjem za substituirane kinazolinone
US9073878B2 (en) 2012-11-21 2015-07-07 Zenith Epigenetics Corp. Cyclic amines as bromodomain inhibitors
US9765039B2 (en) 2012-11-21 2017-09-19 Zenith Epigenetics Ltd. Biaryl derivatives as bromodomain inhibitors
CA2895905A1 (en) 2012-12-21 2014-06-26 Zenith Epigenetics Corp. Novel heterocyclic compounds as bromodomain inhibitors
CN107530356A (zh) 2015-03-13 2018-01-02 雷斯韦洛吉克斯公司 用于治疗补体相关疾病之组合物及治疗方法

Also Published As

Publication number Publication date
AR202946A1 (es) 1975-07-31
DE2349024A1 (de) 1975-04-10
NL7412747A (nl) 1975-04-01
NO743449L (enExample) 1975-04-28
FR2244492A1 (enExample) 1975-04-18
DD114599A5 (enExample) 1975-08-12
AU7374074A (en) 1976-04-01
US3965128A (en) 1976-06-22
DK507974A (enExample) 1975-06-09
LU70985A1 (enExample) 1975-03-06
ZA746131B (en) 1975-09-24
IL45629A0 (en) 1974-11-29
JPS5059362A (enExample) 1975-05-22
SE7412058L (enExample) 1975-03-27
BE820381A (fr) 1975-03-26

Similar Documents

Publication Publication Date Title
AU476761B2 (enExample)
AR201235Q (enExample)
AR201231Q (enExample)
AU474838B2 (enExample)
FI280574A7 (enExample)
AU476714B2 (enExample)
AR201229Q (enExample)
AU476696B2 (enExample)
AR199451A1 (enExample)
AU477823B2 (enExample)
AR197627A1 (enExample)
AR196382A1 (enExample)
AR195311A1 (enExample)
AR201432A1 (enExample)
AR195948A1 (enExample)
AR193950A1 (enExample)
AU476873B1 (enExample)
AR200885A1 (enExample)
AR200256A1 (enExample)
AU477824B2 (enExample)
AR196212Q (enExample)
AR196123Q (enExample)
BG18744A1 (enExample)
AU479562A (enExample)
AU479539A (enExample)